GRI Bio GRI
NASDAQ GRI
$1.97 -0.03 (-1.74%)
As of: Sep 30, 2026 · 3:43 PM EDT

GRI Bio (GRI) Debt Ratio (2020 - 2022)

Updated

GRI Bio's (GRI) Debt Ratio stood at 1.57 in Q4 2022.

Analysis

GRI Bio (GRI) Debt Ratio (2020 - 2022) Analysis & Trends

  • Across earlier years, Debt Ratio came in at 0.06 in FY2020.
  • The Q4 2022 figure is the lowest quarterly Debt Ratio since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.24
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.52
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.42
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.31
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.00
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.60
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 GRI Bio 3.61 Mn 3.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.57
Dec 31, 2020 0.06
API Access

GRI Bio Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=GRI&period=max&api_key=YOUR_API_KEY